Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C5H7NO3 |
Molecular Weight | 129.114 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)[C@@H]1CCC(=O)N1
InChI
InChIKey=ODHCTXKNWHHXJC-VKHMYHEASA-N
InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1
Molecular Formula | C5H7NO3 |
Molecular Weight | 129.114 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.currentscience.ac.in/Volumes/102/02/0288.pdfhttps://www.drugs.com/otc/121041/cleansing-foaming-gel-acne-pro-skin.html | https://www.ncbi.nlm.nih.gov/pubmed/25727335 | https://www.ncbi.nlm.nih.gov/pubmed/21834944 | https://www.ulprospector.com/en/na/PersonalCare/Detail/6637/223524/EcoCare-Zinclean | http://www.scalp-health.com/zinc-pca.htmCurator's Comment: description was created based on several sources, including
http://www.cir-safety.org/sites/default/files/pca.pdf
Sources: http://www.currentscience.ac.in/Volumes/102/02/0288.pdfhttps://www.drugs.com/otc/121041/cleansing-foaming-gel-acne-pro-skin.html | https://www.ncbi.nlm.nih.gov/pubmed/25727335 | https://www.ncbi.nlm.nih.gov/pubmed/21834944 | https://www.ulprospector.com/en/na/PersonalCare/Detail/6637/223524/EcoCare-Zinclean | http://www.scalp-health.com/zinc-pca.htm
Curator's Comment: description was created based on several sources, including
http://www.cir-safety.org/sites/default/files/pca.pdf
Zinc Pidolate (Zinc PCA) is a topical skin product with purifying, astingent, anti-inflammatory, antiseptic activity. It has long been used as a cosmetic ingredient, because of its astringent and anti-microbial properties. Zinc Pidolate has also being shown to be effective against halitosis. Zinc PCA prevents the UV-induced MMP-1 production in vitro by suppressing the activation of AP-1. Zinc PCA was also able to enhance type I collagen synthesis in NHDFs, by increasing the expression of the mRNA encoding the ascorbic acid transporter SVCT2 in non-UV irradiated
NHDFs, which suggests its promising effect against not only photoaged skin but also for the simple atrophic change of intrinsic skin ageing. Zinc PCA is able to suppress sebum secretion by inhibiting 5-α reductase in hyperseborrhea, to suppress body odor by forming zinc salts with short-chain fatty acids, to suppress wrinkles by inhibiting AP-1 to and inhibit bacterial growth including acne related Propionibacterium acnes.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3271 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21834944 |
|||
Target ID: P02452|||Q15176|||Q9UML6 Gene ID: 1277.0 Gene Symbol: COL1A1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21834944 |
|||
Target ID: CHEMBL2111421 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21834944 |
|||
Target ID: CHEMBL612639 |
|||
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | CLEANSING FOAMING GEL ACNE PRO SKIN- zinc pidolate gel Approved UseLange Gel will turn into foam, during application. It will cleanse skin thoroughly without any dryness effect, in order to avoid hyperseboohea phenomenon, a main cause of acne. Launch Date2012 |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | EcoCare™ Zinclean Approved UseUse in anti-dandruff shampoos |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of a model protease--pyroglutamate aminopeptidase by a natural oligosaccharide gum from Hakea gibbosa. | 2001 Jan 16 |
|
Characterization of cigar tobaccos by gas chromatographic/mass spectrometric analysis of nonvolatile organic acids: application to the authentication of Cuban cigars. | 2001 Mar |
|
Stability and CTL-activity of P40/ELA melanoma vaccine candidate. | 2001 Sep-Dec |
|
Expression and prognostic significance of lysozyme in male breast cancer. | 2002 |
|
Allatostatins of the tiger prawn, Penaeus monodon (Crustacea: Penaeidea). | 2002 Jun |
|
Methacrylate derivatives incorporating pyroglutamic acid. | 2002 Nov-Dec |
|
Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity. | 2002 Sep 3 |
|
Solution structure of the cytotoxic RNase 4 from oocytes of bullfrog Rana catesbeiana. | 2003 Feb 28 |
|
[Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone]. | 2003 Jan-Feb |
|
[Evolution of the neuroprotection concept]. | 2003 Mar-Apr |
|
[Characteristics of pyrrolidone pharmacokinetics in rats]. | 2003 Nov-Dec |
|
Glutamine in commercial liquid nutritional products. | 2004 Aug 11 |
|
Toward the synthesis of pyroglutamate lauroyl ester: biocatalysis versus chemical catalysis. | 2004 Feb |
|
Expression, purification, and characterization of avian Thy-1 from Lec1 mammalian and Tn5 insect cells. | 2004 Feb |
|
Chemical characterization of a lambda I amyloid protein isolated from formalin-fixed and paraffin-embedded tissue sections. | 2004 Mar |
|
Synthesis of (2S,3S)-3'-fluoroisoleucine. | 2004 Mar 7 |
|
Skin secretion of the toad Bombina variegata contains multiple insulin-releasing peptides including bombesin and entirely novel insulinotropic structures. | 2004 Mar-Apr |
|
Synthesis of (2S,3R)-[3',3',3'-2H3]-valine and (2S,3S)-4-fluorovaline. | 2004 May 7 |
|
Preventing the spontaneous modification of an HLA-A2-restricted peptide at an N-terminal glutamine or an internal cysteine residue enhances peptide antigenicity. | 2004 May-Jun |
|
Discrepin, a new peptide of the sub-family alpha-ktx15, isolated from the scorpion Tityus discrepans irreversibly blocks K+ -channels (IA currents) of cerebellum granular cells. | 2004 Oct 15 |
|
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. | 2005 Jul |
|
CLPM: a cross-linked peptide mapping algorithm for mass spectrometric analysis. | 2005 Jul 15 |
|
Total synthesis of pinnamine and anatoxin-a via a common intermediate. A caveat on the anatoxin-a endgame. | 2005 Jul 8 |
|
Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme. | 2005 Sep |
|
Synthesis of 1,3-dioxo-hexahydropyrido[1,2-c][1,3]diazepine carboxylates, a new bicyclic skeleton formed by ring expansion-RCM methodology. | 2005 Sep 21 |
|
Thermostability and in vitro digestibility of a purified major allergen 2S albumin (Ses i 1) from white sesame seeds (Sesamum indicum L.). | 2005 Sep 25 |
|
CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefacts. | 2006 Feb |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:30:36 GMT 2023
by
admin
on
Sat Dec 16 16:30:36 GMT 2023
|
Record UNII |
SZB83O1W42
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
75089-3
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
LOINC |
13700-0
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
DSLD |
2731 (Number of products:44)
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
NCI_THESAURUS |
C29703
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
LOINC |
29872-9
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
LOINC |
29522-0
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
LOINC |
53394-3
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
LOINC |
53232-5
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
LOINC |
43633-7
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/16/1673
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
760414
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
DTXSID6046260
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
143034
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
16010
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
155060
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | RxNorm | ||
|
PYROGLUTAMIC ACID
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
58402
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
1589029
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
18183
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
m9383
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | Merck Index | ||
|
4079
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
98-79-3
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
30652
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
SZB83O1W42
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
7405
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
DB03088
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
100000081944
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
202-700-3
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
SUB09825MIG
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
57606
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
C82933
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
SZB83O1W42
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY | |||
|
CHEMBL284718
Created by
admin on Sat Dec 16 16:30:38 GMT 2023 , Edited by admin on Sat Dec 16 16:30:38 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|